Deleterious variants in the transcription factor early B-cell factor 3 (EBF3) are known to cause a neurodevelopmental disorder (EBF3-NDD). We report eleven individuals with EBF3 variants, including an individual with a duplication/triplication mosaicism of a region encompassing EBF3 and a phenotype consistent with EBF3-NDD, which may reflect the importance of EBF3 gene-dosage for neurodevelopment. The phenotype of individuals in this cohort was quite mild compared to the core phenotype of previously described individuals. Although ataxia tended to wane with age, we show that cognitive difficulties may increase, and we recommend that individuals with EBF3-NDD have systematic neuropsychological follow-up.
Objective To characterize the genetic background of molecularly undefined childhood-onset ataxias in Finland. Methods This study examined a cohort of patients from 50 families with onset of an ataxia syndrome before the age of 5 years collected from a single tertiary center, drawing on the advantages offered by next generation sequencing. A genome-wide genotyping array (Illumina Infinium Global Screening Array MD-24 v.2.0) was used to search for copy number variation undetectable by exome sequencing. Results Exome sequencing led to a molecular diagnosis for 20 probands (40%). In the 23 patients examined with a genome-wide genotyping array, 2 additional diagnoses were made. A considerable proportion of probands with a molecular diagnosis had de novo pathogenic variants (45%). In addition, the study identified a de novo variant in a gene not previously linked to ataxia: MED23. Patients in the cohort had medically actionable findings. Conclusions There is a high heterogeneity of causative mutations in this cohort despite the defined age at onset, phenotypical overlap between patients, the founder effect, and genetic isolation in the Finnish population. The findings reflect the heterogeneous genetic background of ataxia seen worldwide and the substantial contribution of de novo variants underlying childhood ataxia.
Objective: To evaluate the ictal semiology in seizures originating in the precuneus and to help guide seizure interpretation within the framework of presurgical evaluation. Methods: This systematic review followed a Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) and a Quality Assessment tool for Diagnostic Accuracy Studies (QUADAS2) based approach. We searched PubMed and Embase with keywords related to the precuneus, parietal or posterior epilepsy, video‐EEG, and epilepsy surgery. Included studies report patients with seizures originating in the precuneus and video‐EEG‐based description of seizure symptoms. Screening and data extraction of all studies were performed by two independent reviewers. The summary of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: Nine studies reporting 29 patients were included in the final analysis. The most common symptoms at the onset of seizures were vestibular symptoms, visual illusions and hallucinations, and body perception illusions. Motor symptoms were either elementary or complex motor phenomena that emerged during seizure propagation. However, the overall quality of evidence remained moderate or low. Significance: This systematic review suggests typical seizure symptoms associated with precuneus seizures. However, it also shows a paucity of reports on precuneus seizures. Larger prospective studies with more detailed anatomo‐electro‐clinical data are needed to better understand seizures with precuneal origin within the entity of posterior cortex seizures.
Background: Neurological patients represent a small yet resource‐demanding group in pediatric emergency departments (PEDs). Their pathways and resource needs remain poorly understood. This population‐based real‐world data study aims to bridge this gap. Methods: We analyzed neurological visits from 2021 to 2023 at the sole PED serving 300,000 children using process mining and statistical analysis. Neurological visits included patients triaged for neurologist evaluation and those with neurological complaints and/or diagnosis. Results: We identified 4854 neurological visits, constituting 5% of PED visits. Seizure and headache comprised 64% of the chief complaints; seizures dominated the highest acuity visits, while headache was linked to visits with lower acuity. Neurological patients had a nearly fivefold increased risk of requiring immediate lifesaving interventions compared to non‐neurological patients. Half of the highest acuity patients were 1–5 years old. Patient disposition was most strongly associated with acuity: 81% of highest acuity patients were admitted and 15% of them to the pediatric intensive care or surgical unit, whereas only 18% of stable patients were hospitalized. Variability of patient pathways was moderate. 87% of patients adhered to one of four most common pathways where disposition decision was made without advanced testing. Over 30 pathways were identified for patients needing advanced tests. These patients presented with higher acuity, non‐seizure complaints and increased admissions. Conclusion: This population‐based study pioneers process mining for analyzing patient care processes and resource utilization of neurological patients at the PED. It highlights the critical nature of pediatric neurological emergencies and uncovers the variability of patient needs and pathways.